Evogene and Marrone Bio Innovations Disclose Positive Results in Insect Control Collaboration
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Nasdaq futures lead Wall St gains as oil retreat eases inflation worries
- Oil prices edge lower on easing fears over Saudi supply disruption
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Jefferies Cuts Price Target on Marine Bio (MBII) Following a Light 1Q
May 17, 2016 8:11 AM EDTJefferies maintained a Hold rating on Marrone Bio Innovations (NASDAQ: MBII), and cut the price target to $0.75 (from $1.00), following the company's 1Q earnings report. MBII reported a loss of $0.38, $0.13 worse than consensus. Sales rose 30%, with a 79% increase in product shipments.
Analyst Laurence... More
